Catecholamine prodrugs for use in the treatment of Parkinson's disease
US12391650B2 · kind B2 · utility
0Cited by
22References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 19, 2020 |
| Grant date | Aug 19, 2025 |
| Priority date | — |
| Expiry date | Oct 9, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/5765
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compounds of formula (Id) that are prodrugs of catecholamine for use in treatment of neurodegenerative diseases and disorders. The present invention also provides pharmaceutical compositions comprising compounds of the invention and methods of treating neurodegenerative or neuropsychiatric diseases and disorders using the compounds of the invention, in particular Parkinson's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.